JavaScript & Algorithm Fundamentals
Frontend coding interviews focus on DOM manipulation, async patterns, and data structure problems with JavaScript-specific nuances.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Frontend interviews blend algorithmic thinking with UI/UX implementation skills and modern framework expertise.. Explore key insights and preparation tips to help you excel in your interview process.
Frontend coding interviews focus on DOM manipulation, async patterns, and data structure problems with JavaScript-specific nuances.
Design scalable web applications, component architectures, and client-side performance optimization strategies.
Component Design
Reusable UI systems
State Management
Redux, Context patterns
Performance
Bundle optimization, caching
Different companies emphasize different frontend skills based on their product needs and technical stack.
Meta
React internals, performance optimization
Stripe
TypeScript, payment UI patterns
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers approximately 65% lower housing costs compared to San Francisco, with median rent around $1,400 vs $4,000+ in the Bay Area. Your frontend engineer salary stretches significantly further while maintaining access to major East Coast markets and a growing local tech scene.
Baltimore's frontend engineer market shows lower saturation than major tech hubs, creating better opportunities for career growth and competitive positioning.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States